“Our findings suggest that plytidepsin is a promising candidate for the treatment of COVID-19,” says an article in Science.
It is noted that the studies were carried out "in vitro" and on animals.
Tests of the drug in mice have shown a decrease in the rate of virus replication in the lungs.
Earlier, the chief infectious disease specialist of the Moscow Department of Health, the head physician of the Infectious Disease Hospital No. 1, Svetlana Smetanina, spoke about the methods of preventing COVID-19.